AADI Aadi Bioscience Inc
Price (delayed)
$1.85
Market cap
$45.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.42
Enterprise value
$5.45M
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which the Company believes that activation of Tie2 may have therapeutic potential. The
Highlights
The debt has contracted by 28% YoY and by 9% from the previous quarter
Aadi Bioscience's revenue has increased by 11% YoY
The company's net income fell by 6% YoY but it rose by 4.9% QoQ
AADI's quick ratio has dropped by 64% year-on-year and by 19% since the previous quarter
The company's equity fell by 40% YoY and by 13% QoQ
Key stats
What are the main financial stats of AADI
Market
Valuations
Earnings
Shares outstanding
24.61M
Market cap
$45.54M
Enterprise value
$5.45M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
2.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.23
Revenue
$23.82M
EBIT
-$65.21M
EBITDA
-$64.57M
Free cash flow
-$53.6M
Per share
Balance sheet
Liquidity
EPS
-$2.42
Free cash flow per share
-$1.98
Book value per share
$3.21
Revenue per share
$0.88
TBVPS
$3.76
Total assets
$101.62M
Total liabilities
$22.83M
Debt
$1.06M
Equity
$78.79M
Working capital
$70.86M
Debt to equity
0.01
Current ratio
4.2
Quick ratio
3.81
Net debt/EBITDA
0.62
Margins
Efficiency
Dividend
EBITDA margin
-271.1%
Gross margin
87.2%
Net margin
-274.8%
Operating margin
-296.7%
Return on assets
-54%
Return on equity
-66.7%
Return on invested capital
-149.8%
Return on capital employed
-82.1%
Return on sales
-273.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AADI stock price
How has the Aadi Bioscience stock price performed over time
Intraday
2.78%
1 week
2.21%
1 month
25.85%
1 year
-66.61%
YTD
-8.42%
QTD
26.71%
Financial performance
How have Aadi Bioscience's revenue and profit performed over time
Revenue
$23.82M
Gross profit
$20.76M
Operating income
-$70.66M
Net income
-$65.44M
Gross margin
87.2%
Net margin
-274.8%
Aadi Bioscience's revenue has increased by 11% YoY
The company's net income fell by 6% YoY but it rose by 4.9% QoQ
The company's gross profit rose by 6% YoY
The operating income has declined by 6% year-on-year but it is up by 5% since the previous quarter
Growth
What is Aadi Bioscience's growth rate over time
Valuation
What is Aadi Bioscience stock price valuation
P/E
N/A
P/B
0.58
P/S
2.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.23
The company's EPS rose by 5% QoQ
AADI's price to book (P/B) is 60% less than its 5-year quarterly average of 1.4 and 7% less than its last 4 quarters average of 0.6
The company's equity fell by 40% YoY and by 13% QoQ
The price to sales (P/S) is 100% less than the 5-year quarterly average of 740.1 and 32% less than the last 4 quarters average of 3.0
Aadi Bioscience's revenue has increased by 11% YoY
Efficiency
How efficient is Aadi Bioscience business performance
The return on invested capital has dropped by 122% year-on-year and by 13% since the previous quarter
The company's return on equity has shrunk by 64% YoY and by 8% QoQ
The return on assets has dropped by 53% year-on-year and by 4.9% since the previous quarter
The company's return on sales rose by 4.9% QoQ and by 3.9% YoY
Dividends
What is AADI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AADI.
Financial health
How did Aadi Bioscience financials performed over time
AADI's quick ratio has dropped by 64% year-on-year and by 19% since the previous quarter
AADI's current ratio has shrunk by 62% YoY and by 19% QoQ
The debt is 99% less than the equity
The company's equity fell by 40% YoY and by 13% QoQ
The debt has contracted by 28% YoY and by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.